Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Vetmedin approved in US

Boehringer Ingelheim Vetmedica's Vetmedin, a treatment for congestive heart failure in dogs, has been approved by the US Food and Drug Administration (FDA). This is seven years after the drug was officially launched. The FDA said that it had met all of its ADUFA (Animal Drug User Fee Act) guidelines for approving new drugs. Boehringer Ingelheim Vetmedica declined to comment on the approval.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts